InBios International, Inc.
Diagnostic Tests & IVD

InBios International, Inc. news and milestones

InBios International, Inc.: 5 headlines on record, 0 headlines in the last 90 days. Its story counts 6 milestones.

Data updated Nov 16, 2026 · Back to the company report
5Headlines
0In 90 days
6Milestones

Headlines

Nov 27, 20242024
Blog
BARDA awards $16 million to InBios to develop a point-of-care lateral flow diagnostic to detect Burkholderia pseudomallei, the bacteria that causes melioidosis. The post November…
Sep 5, 20242024
Blog
InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test The post September 5, 2024 appeared first on InBios International, Inc..
Sep 5, 20242024
Blog
InBios Launches an In Vitro Diagnostic Test for Strongyloidiasis Providing Fast Results The post August 14, 2024 appeared first on InBios International, Inc..
Sep 5, 20242024
Press release · PRNewswire
/PRNewswire-PRWeb/ -- With a late summer surge in COVID-19 cases fueled by new variants, effective, easy-to-use diagnostics are more important than ever....
Aug 14, 20242024
Press release · PRNewswire
/PRNewswire-PRWeb/ -- InBios International Inc., a leading developer and manufacturer of diagnostic tests for emerging infectious diseases and biothreats, is...
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

InBios International, Inc., News. Alion, Nov 16, 2026. https://alion.io/company/inbios/news

.json · .md · CC BY-SA 4.0